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Abstract The rapid technological evolution in the bio-
medical and molecular oncology elds is providing re-
search laboratories with huge amounts of complex and
heterogeneous data. Automated systems are needed to
manage and analyze this knowledge, allowing the dis-
covery of new information related to tumors and the im-
provement of medical treatments. This paper presents
the Laboratory Assistant Suite (LAS), a software plat-
form with a modular architecture designed to assist re-
searchers throughout diverse laboratory activities. The
LAS supports the management and the integration of
heterogeneous biomedical data, and provides graphi-
cal tools to build complex analyses on integrated data.
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Furthermore, the LAS interfaces are designed to ease
data collection and management even in hostile envi-
ronments (e.g., in sterile conditions), so as to improve
data quality.
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1 Introduction
In the post-genomic era with the advent of new tech-
nologies (e.g., microarrays), a huge amount of complex
molecular data are generated with high throughput.
The management of clinical, molecular and biological
data is denitely a challenging task due to the com-
plexity and heterogeneity of data. Moreover, the inte-
gration of heterogeneous molecular data with clinical
and biological information is a major prerequisite to
discovering the main causes of tumors.
Numerous eorts have been devoted to building man-
agement systems that assist researchers during labora-
tory activities. Many commercial Laboratory Informa-
tion Management Systems (LIMS) are available, but
they are usually very expensive and require signicant
human and economic resources to adapt to specic lab-
oratory requirements [7]. The researcher community has
also proposed dierent tools focused on the manage-
ment and the analysis of dierent biological data. For
instance, TreeSNPs [2] manages data generated through
single nucleotide polymorphism (SNP) identication.
Dierently, Screensaver [12] supports the storage and
the comparison of small molecule and RNA screening
data. Other proposed LIMS focus on managing data as-
sociated with mouse colonies. For instance, MausDB [10]
integrates standard mouse colony management, phe-
notyping workow scheduling and mouse phenotyping
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result data management. However, these systems are
often mainly focused on managing few kinds of data
related to a particular set of experiments or kind of
source. Moreover, many of these tools do not currently
allow the integration and analysis of experimental data.
From 2004, a number of tools have been developed
under the Cancer Biomedical Informatics Grid (caBIG)
project [8], addressing both the management and the
analysis of biomedical data. For instance, caTissue pro-
vides biospecimen inventory, tracking, and basic an-
notation, while VISDA [13] allows clustering analyses
on high dimensional and complex biomedical datasets.
However, the end user data accessibility in caBIG tools
may be compromised by the object model complexity
and overly generic terminologies [9]. Even if these tools
belong to the same project, the integration of experi-
mental data is in many cases troublesome or unfeasible.
In this paper, we propose the Laboratory Assistant
Suite (LAS) platform that assists the researchers in dif-
ferent laboratory activities. Its modular architecture al-
lows managing dierent kinds of raw data (e.g., biolog-
ical, molecular) and tracking experimental data. Each
LAS module is tailored to handle specic activities or
kinds of data, but it is plugged into a broader and uni-
form framework and thus integrates with the activi-
ties managed by other modules almost eortlessly. The
platform can be easily extended by developing and in-
tegrating new modules, should the need arise to man-
age new laboratory activities. User interfaces are de-
signed to be practical in hostile environments where re-
searchers should minimize their interactions with the
system (e.g., in sterile conditions). Furthermore, the
platform provides a graphical query tool to integrate
dierent resources and performs analyses in a grid en-
vironment in order to extract knowledge related to tu-
mors. The paper is organized as follows. Section 2 de-
scribes the context in which the LAS has been studied
and developed. Section 3 discusses the main features of
the system architecture, while Section 4 presents the six
modules that currently make up the system. Section 5
describes how the proposed system can support labora-
tory research in diverse real scenarios. Finally, Section 6
draws conclusions and presents future developments.
2 Context
A multitude of procedures are performed daily in re-
search laboratories to analyze dierent biological and
medical aspects of tumors, to the aim of discovering
new knowledge and improving therapies. To model our
environment, we analyzed a subset of procedures de-
veloped and performed in the research laboratories of
our institution. In particular, we focused our attention
Fig. 1 Dataow including the xenopatients approach.
on the procedures based on the xenopatient experimen-
tal pipeline [1]. This approach is based on the serial
transplantation of human tumor specimens in immuno-
compromised animals. The aim is to help in translating
the correlative information emerging from data integra-
tion into clinically relevant and functionally validated
biomarkers. In the following we briey introduce the
context in which the LAS platform has been proposed
by describing the main activities of a research study
including the xenopatients approach (see Figure 1).
Tumor specimens are initially collected from surgi-
cal interventions. From each individual patient-derived
material a set of aliquots are generated, i.e., vital, RNA
Later and snap-frozen. According to the characteristics
of the aliquots and the purpose of the research study,
dierent operations can be performed: (i) storage in
dedicated containers, (ii) extraction of derived aliquots
(e.g., DNA, RNA), and (iii) implantation in immuno-
compromised animals (i.e., xenopatients). Researchers
can dene treatment protocols to monitor the evolu-
tion of the tumor mass within the implanted animals by
means of measurements, and evaluate the response to
drugs. Furthermore, they can generate new tissue sam-
ples from these animals for further analyses. Indeed,
all (derived) aliquots can be exploited for experimental
analyses with dierent technologies, such as microarray
and DNA sequence experiments.
To the best of our knowledge, the procedures adopted
in our experimental pipeline are largely standardized
and they reect common practice in the oncological re-
search eld. Thus, we believe that most functionalities
oered by the system we are developing could be use-
ful to other researchers from dierent institutions. The
LAS software platform is freely available from the au-
thors for use by interested researchers.
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3 Architecture
The LAS architecture is the result of a joint eort by
both IT and biomedical researchers, in an attempt to
design a system to eectively manage the entire ex-
perimental and analysis process. Since the laboratory-
related procedures can be subdivided into dierent lev-
els according to data complexity and purpose, the LAS
has been designed as a three-tier architecture. Each tier
addresses a specic issue and interacts with the other
tiers by means of well-dened interfaces. We modeled
the platform in the following tiers: (i) operative, (ii) in-
tegration, and (iii) analysis.
In the general architecture of the LAS, each tier in-
cludes a set of fully-edged applications, or modules.
While the lower tier is mainly concerned with the col-
lection of experimental data, the modules and data
managed by the upper tiers are characterized by an
increasing level of abstraction. Lower tiers can service
requests generated by the upper tiers and provide the
data needed to carry out complex tasks (e.g., data in-
tegration and/or analysis).
The operative tier is responsible for collecting, stor-
ing and tracking raw experimental data from dierent
sources (e.g., xenopatients, microarrays), each handled
by a specic software module. Modules in this tier are
meant to work in close interaction with the researchers
in a laboratory setting. Therefore, graphical user inter-
faces (GUIs) are tailored to ease data entry in hostile
environments and assist researchers throughout their
experiments in order to improve data quality. Interac-
tion is designed to be especially lean with the aid of spe-
cial input devices, such as touch-screen notepads and
barcode scanners, available in our research institute.
The integration tier is aimed at integrating dierent
types of raw experimental data by means of complex
queries. Ad-hoc identiers have been adopted through-
out the databases that make it possible to correlate
dierent biological entities. The integrated data can be
browsed or visualized as graphs (e.g., genealogy trees).
In addition, they can be fed to the analysis tier and
enriched by means of annotations. For instance, a pop-
ulation of xenopatients can be annotated as responsive
to a given drug according to statistical analyses.
The analysis tier allows the denition of a workow
for the analysis of integrated data. Users can design
their analysis session by selecting and cascading one
or more analysis building blocks. The analysis process
ultimately generates annotations, which are sent to the
integration tier and stored in the database, and it can
optionally export data for visualization with external
tools.
Each LAS module is a web-based application imple-
mented in Python and exploiting Django 1, an open-
source web application framework which follows the
Model-View-Controller [5] architecture. In this way, end
users can access the applications from virtually any
Internet-enabled device and without almost any sys-
tem requirements. This aspect is fundamental to pro-
vide data access also in hostile environments (e.g. ster-
ile conditions) with wireless devices. According to the
data structure and type, a relational DBMS (MySQL 2)
and/or a non-relational database engine (MongoDB 3)
are exploited to provide persistent storage for the exper-
imental data and the annotations. Dierent user privi-
leges can be dened in order to grant or restrain access
to dierent application functionalities. Furthermore, all
user activity is tracked within each module by means of
audit trail procedures. A set of APIs (Application Pro-
gramming Interface) are provided to make some of the
functionalities oered by each application available to
the others and thus permit data exchange among dier-
ent applications. Finally, thanks to the modular archi-
tecture, dierent modules can be installed on dierent
machines, so as to distribute the workload of the entire
system. A grid environment is also being integrated to
increase the computational resources available for the
analysis tasks.
4 Modules
The LAS platform is designed to be easily updated
when new laboratory or analysis activities need to be
managed. To date, the BioBanking, Xenopatients, and
Storage Management Modules have been fully imple-
mented and deployed for use by the research sta. Most
functionalities of the Multi-Dimensional Data Manager
are already available, while the Microarray Manage-
ment Module is currently under testing. The Analysis
Developer Module is still being developed. In the follow-
ing we present the main functionalities of each module.
4.1 BioBanking Management Module
With the rapid advances in biomedical and genetic tech-
nologies, collections of human biological materials have
attracted increasing attention from the researcher com-
munity. Such collections, named biobanks, represent a
fundamental resource for the research and the diagnosis
of dierent pathologies, and the study of possible ther-
apeutic applications. Based on the types of biological
1 https://www.djangoproject.com/
2 http://www.mysql.com/
3 http://www.mongodb.org/
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materials they store, biobanks are commonly divided
into tissue and genetic biobanks. The BioBanking Man-
agement Module (BBMM) addresses both issues.
The scope of the BBMM spans a wide range of activ-
ities, including management of biological samples and
laboratory instrument data, as well as support to a
number of laboratory-related procedures. In particular,
the module can currently handle the following activities
and the corresponding data.
(i) Collection of biological material from surgical
intervention and acquisition of aliquots from external
laboratories. Aliquots stored in the system are charac-
terized by features such as tumor type (e.g., colorectal),
tissue type (e.g., liver metastasis), number of fragments
and source hospital or laboratory.
(ii) Measurement of aliquot physical characteristics,
such as volume, concentration, purity and quality.
(iii) Derivation of new biological materials (e.g., DNA,
cDNA) from the aliquots stored in the biobank.
(iv) Tracking of consumables involved in laboratory
operations, to manage the warehouse and monitor as-
sociated quality indexes.
Particular care has been devoted to the design of the
graphical user interfaces, so that they closely match the
researcher's physical working environment. They have
been designed to also work on tablet devices, to allow
use in hostile environments, such as in sterile conditions
or during surgical interventions. For instance, Figure 2
shows the aliquot collection interface. The application
shows several panels, i.e., vital, FFPE, RNA later and
snap-frozen (block B in the gure), that graphically rep-
resent the physical working containers in which sample
aliquots will be stored. Containers of each type can be
quickly loaded by scanning their barcode, or by manu-
ally typing it. The layout of each container is automat-
ically retrieved from the Storage Management Module.
Each cell, representing an aliquot, is colored accord-
ing to the type of tissue, and reports the number of
aliquot fragments it currently stores. Clicking (or tap-
ping) on an empty cell stores one fragment of aliquot of
the current tissue type in the corresponding container
location; each further click (or tap) increments the frag-
ment count by one. The tissue type being collected is
shown on the top left hand side (block A).
4.2 Storage Management Module
Research laboratories make use of several types of con-
tainers (e.g., freezers, racks, plates, tubes) to store bio-
logical material. The main issue in designing a storage
management system is to model how containers can in-
teract with each other. For instance, a freezer of a given
Fig. 2 The BBMM aliquot collection interface.
manufacturer and model can host dierent racks and/or
plates. The inner layout of the freezer may also change
according to the type of hosted containers.
This issue is addressed in the Storage Management
Module through a exible database schema. Dierent
container types can be dened, along with a geometry,
describing how child containers are laid out, a parent
container (if any), and a set of relevant features that
will be recorded for each container of that type (e.g.,
manufacturer, model and storage temperature for freez-
ers, aim and aliquot type for plates).
The module shows the current usage of each con-
tainer, and allows the end user to move containers and
change their aim. All the modules belonging to the LAS
can easily retrieve the information associated with a
given container through the provided API, using its
unique identier, such as a barcode. In this way, labo-
ratories can exploit barcode readers to streamline data
entry procedures.
4.3 Xenopatients Management Module
One of the crucial activities in our institution, manage-
ment of the immunocompromised animals (i.e., xenopa-
tients) is supported by this module. It enables tracking
and monitoring of the xenopatient life cycle, from their
acquisition by the research institute to their death. The
functionalities provided by this module include the fol-
lowing.
(i) Loading of data (i.e., barcode and gender) for a
batch of mice (characterized by the same status, strain,
age, source, and owner) into the system. Mice can be
equipped with RFid tags, allowing quick insertion of
each animal into the database and easy identication
at a later time.
(ii) Management of tumor tissue implants into the
available xenopatients. The XMM eectively handles
this operation by accessing the BioBanking and Storage
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modules (through the appropriate APIs) and retrieving
the tumor aliquots currently stored in the source con-
tainer (e.g., plate, tube), whose available quantity is
updated accordingly.
(iii) Monitoring of tumor growth within the xenopa-
tients. Qualitative and quantitative measurements of
the tumor mass are tracked for each mouse, and treat-
ments, aimed at assessing the eectiveness of given drugs,
can be assigned to measured xenopatients. Each treat-
ment is composed of several phases, each associated
with dierent kinds of information. For instance, the
drug, the administration mode, the dose, and the ad-
ministration frequency can be dened.
(iv) Management of tumor explants, marking the
end of the xenopatient life cycle. A number of tumor
tissue aliquots are generated and made available for fu-
ture implants. Explant operations also cooperate with
the BioBanking and Storage Management Modules, to
display destination plates and transmit data about gen-
erated aliquots.
During the xenopatient life cycle, the user can as-
sign each mouse dierent operations to be performed,
which can be subsequently validated by a supervisor.
The module supports the supervisor in the decision-
making process by means of graphical utilities, and
tracks all decisions (see Section 5.1).
4.4 Microarray Management Module
Microarray technology has become a fundamental tool
in genomic research to analyze thousands of gene ex-
pression values with a single experiment [4,6]. The anal-
ysis of this huge amount of data aims to identify the set
of genes that are highly correlated with the phenotype.
Thus, tracking both the biological information related
to the sample source and the entire experimental pro-
cess is necessary to assess the quality of the analyses
and improve further integration tasks. The Microarray
Management Module tracks all information related to
the various steps of a microarray experiment, providing
support to the following tasks.
(i) Planning of dierent experiments by assigning
each biological sample a position within a microarray
chip. Automatic assignment is also possible to optimize
the chip exploitation.
(ii) Hybridization of chips according to specic pro-
tocols, tracked by the system.
(iii) Scan events. Based on additional data provided
by the chip manufacturer, the system generates an in-
put le for the microarray scanner machines. Quality
measures about the scan event are also tracked for fur-
ther analyses.
(iv) Collection and storage of the microarray raw
data obtained from the scans. Such data are stored in
a content repository and linked to the corresponding
sample within the database. To automatically feed the
content repository and update the database each time a
scan is performed, we provide a client/server tool writ-
ten in Java. The client program retrieves the microarray
raw data produced by the scanners and sends it to the
server hosting the content repository. When new data
are received by the server, the relevant information is
extracted to feed the content repository, and links to
the raw data are added to the database.
4.5 Multi-dimensional Data Manager
The integration of dierent biological and molecular
data is a fundamental task to discover new knowledge
related to tumors. The Multi-Dimensional Data Manger
(MDDM) aims at extracting all information of interest
from the operative tier in a uniform way by exploiting
graphical tools. In the following we present the main
ideas on which the functionalities are built.
The MDDM allows performing heterogeneous and
complex queries on the data managed by the opera-
tive tier modules. The user denes the result set of
each query, designed as a workow, by cascading dif-
ferent query blocks. For each query block, objects of
the corresponding type will be retrieved (e.g., aliquots,
xenopatients), based on the ltering conditions speci-
ed by the user. All SQL queries actually built by the
system to process each query block are hidden to the
nal user. The MDDM query editor assists the user in
designing her query by performing coherency checks at
run-time and forbidding operations that are not well-
dened (e.g., cascading blocks corresponding to unre-
lated object types or intersecting disjoint sets of ob-
jects). To ease the use of the system by unexperienced
users, a set of wizards based on predened workows
are also provided. In Figure 3 the query editor screen
is reported. The query blocks are shown on the left
hand side of the editor (block A in Figure 3) and cat-
egorized according to the module from which the data
are drawn (e.g., ask icon for biobank data, mouse icon
for xenopatient data). The user can drag and drop the
query blocks onto the workow editor (block B) and
build the workow of the query by connecting them.
Filtering conditions may be specied for each block by
clicking the arrow button. Set operators, listed in block
C, can also be used in the workow. Once the workow
has been dened, the user can assign a title and a de-
scription to the query (block D). Finally, she can simply
run the query or save it in the system to be reused in
the future for dierent purposes (block E).
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Fig. 3 The MDDM query editor interface.
Each object returned by a query is inserted in a
non-relational database. With this technology, hetero-
geneous objects can be stored without dening a xed
structure for the information. Thus, MDDM can easily
store dierent biological and molecular objects and add
other information (i.e., annotations) derived from fur-
ther analyses. For instance, researchers can annotate
a set of objects with their response to a drug treat-
ment, according to statistical analysis performed on
corresponding molecular and biological data. The inte-
grated data can also be browsed or visualized by means
of graph representations (e.g., genealogy trees).
Communication among MDDM and the other mod-
ules exploits the APIs dened by each module. Each
API of interest for the integration task, and its related
parameters, are registered into MDDM, so that a cor-
responding query block is created and made available
in the editor. Since some lter parameters may change
over time, or new operative modules may become avail-
able, a procedure is included to update the MDDM con-
guration and avoid inconsistencies.
4.6 Analysis Developer Module
Genomic data encode many biological insights whose
investigation can be the basis for dramatic advances in
the eld of molecular oncology. The analysis of dierent
(integrated) biological and molecular data is fundamen-
tal in any research laboratory. Several tools have been
proposed with dierent purposes. However, to the best
of our knowledge, a tool that can integrate many dif-
ferent analysis methods is missing. The Analysis Devel-
oper Module aims to provide the end user with a web-
based tool to dene an analysis workow. The graphic
interface is based on the same idea exploited in the
MDDM for the query construction. In this way, the
user can focus her attention on the analysis tasks and
needs not concern herself with any issue related to data
formats and conversions. Each block represents an algo-
rithm integrated in the platform, while data exchange
among the blocks and the collection of results are han-
dled by the Analysis Developer Module in a transparent
way.
To enhance the computational resources available
for analysis, we are currently building a grid environ-
ment based on the Apache Hadoop framework 4. It al-
lows the distributed processing of large data sets across
clusters of computers, using a simple programming model.
5 Use cases
The following sections illustrate how the LAS platform
can concretely support laboratory research. We present
two real application scenarios we encountered in our
laboratories, and describe the LAS tools addressing these
issues. Even though the idea and the design of such
tools were based on the functional requirements of our
laboratories, we believe they reect common practice in
the oncological research eld and are general enough to
be useful to other researchers from other institutions.
4 http://hadoop.apache.org
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Fig. 4 The XMM experiment review interface.
5.1 Use case 1: Experiment review
Immunocompromised mice that have been implanted
with a tumor mass are regularly measured by labora-
tory technicians to monitor the growth of the tumor
and assess the eectiveness of treatments. Through the
LAS interface, technicians record the observed values
and may propose a given course of action for each mouse
(e.g., start/stop a treatment, explant). Such measure-
ments and actions are reviewed by a supervisor through
the \Experiment review" screen (see Figure 4). The
screen initially displays a list of all experimental groups
for which new measurements exist (block A). When an
experimental group is selected, its measurements and
all associated pending actions are shown in the bottom
table (block D). To ease the supervisor's task, any pend-
ing action awaiting approval is highlighted, while fur-
ther information is available in the other tabs (e.g., his-
torical measurement record for each mouse). Moreover,
a plot showing the average variation of the tumor mass
over time for each treatment arm (block C) provides a
useful tool to support the supervisor in the decision-
making process. The supervisor may accept the actions
proposed by the technician for any measurement, or
she may modify or reject them, by means of a set of
buttons (block B). She may also add comments, such
as explanations or future directions. Once the review
is complete, a report is displayed, including all actions
(both approved and rejected or modied ones), and sent
to both the supervisor and the technician.
5.2 Use case 2: Paternity test
In the xenopatient experimental pipeline, we dene the
xenogenealogy as the genealogy tree representing the
relationships among the xenopatients implanted with
original or passaged tumors. To support the robustness
and the predictive power of this experimental proce-
dure, serially passaged tumors should retain the mor-
phologic and genomic features of their original coun-
terparts. Thus, the researchers in our institution per-
form mutational analyses on both a representative se-
ries of matched primary and xenografted cases. The
LAS can automatically select the aliquots, explanted
from the xenopatients belonging to a given xenoge-
nealogy, to perform these paternity tests. The selection
procedure is scheduled to be automatically performed
for each xenogenealogy stored in the system twice per
month, but it can also be triggered by the researcher
on a specic case. For instance, the user can retrieve
the genealogy of interest by performing a query with a
set of constraints using the MDDM module. Figure 3
shows a query retrieving the mice explanted in a given
time period (i.e., after July, 1st 2012) and belonging
to a colorectal tumor collection. The workow of the
query starts retrieving all colorectal tumor collections
(Collections block). This set of collections is exploited
to lter the aliquots in the biobank (Aliquots block)
and select the explants from mice, performed after July,
1st 2012, that have generated these aliquots (Explant
block). Finally, the mice involved in these explants are
returned to the user (Mice block). The result set is pre-
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Fig. 5 Xenegenealogy with marked xenopatients.
sented as a table reporting the features of each mouse.
By selecting the genealogy identier associated with a
given mouse, additional information can be retrieved by
means of query templates and visualized on the xeno-
genealogy. For instance, in Figure 5, mice whose DNA
and RNALater aliquots are stored in the biobank are
marked on the xenogenealogy. Finally, the user can ask
the system to identify the aliquots for the paternity test
on the xenogenealogy. The selection of a set of represen-
tative xenopatients is exploited to cover all the branches
of the genealogy tree and identify xenopatients from
which DNA has not yet been extracted (i.e., on which
the paternity test has never been performed before). In
both scenarios (manual and automatic selection of can-
didates for the paternity test), an email with the set
of identied aliquots and the associated xenogenealogy
with marked mice is sent to the researcher and her su-
pervisor.
5.3 Usage statistics
The rst modules of the LAS platform have been ac-
tively employed for research in our institution since
March 2012. To date, about 15 users exploit the BioBank-
ing, Storage and Xenopatients Management Modules in
their daily activity. As of September 2012, the BioBank-
ing database thus includes about 30,000 aliquots of dif-
ferent types (e.g., RNALater, SNAP frozen, DNA, RNA)
belonging to 560 collections, and tracks the collection
of tens of new aliquots every day. The Storage Man-
agement module manages around 200 containers, while
the Xenopatients Management Module is tracking all
the activities performed on approximately 2,900 mice.
By adopting the LAS, the time required for retriev-
ing and analysing data has signicantly decreased. For
instance, to perform the experiment review (described
in Section 5.1), the supervisor would previously need to
manually identify and examine all measurements per-
formed by dierent technicians to make his nal deci-
sions, which should then be transmitted to the tech-
nicians. This would generally require from half to a
full working day. With the current system, which auto-
mates data retrieval, aggregation and communication,
the same task only takes a few minutes.
6 Conclusions and future work
In this paper we presented the Laboratory Assistant
Suite (LAS) platform, designed to assist the researchers
of biological and biomedical laboratories in their activ-
ities. The modular architecture of the system can man-
age heterogeneous and complex data and perform dif-
ferent analyses. Moreover, the graphical interfaces and
the web-based architecture enable the researchers to use
the platform even in hostile environments (e.g., in ster-
ile conditions). Some operative modules are already in
use in the research laboratories of our institution, with
promising results.
Besides completing the MDDMwith annotation man-
agement capabilities, we are developing other operative
modules of the LAS platform. In particular, we are de-
signing a SangerSeq Management Module to handle se-
quencing experiments, track consumables and biologi-
cal materials (e.g., primers), and dene quality controls,
and a Cell-line Management Module to track the life
cycle of cell-lines and monitor the experimental condi-
tions applied to each cell. Furthermore, we are inter-
facing some state-of-the-art analysis approaches with
the Hadoop framework to increase the computational
power available for the Analysis Developer Module. These
methods will be applied on integrated data, including
microarray and xenopatient data.
7 Con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